Mitochondrial Dynamics, ROS, and Cell Signaling: a Blended Overview

Total Page:16

File Type:pdf, Size:1020Kb

Mitochondrial Dynamics, ROS, and Cell Signaling: a Blended Overview life Review Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview Valentina Brillo †, Leonardo Chieregato †, Luigi Leanza *,‡ , Silvia Muccioli ‡ and Roberto Costa ‡ Department of Biology, University of Padova, 35121 Padova, Italy; [email protected] (V.B.); [email protected] (L.C.); [email protected] (S.M.); [email protected] (R.C.) * Correspondence: [email protected]; Tel.: +39-049-827-6343 † These two authors contributed equally. ‡ These authors share senior authorship. Abstract: Mitochondria are key intracellular organelles involved not only in the metabolic state of the cell, but also in several cellular functions, such as proliferation, Calcium signaling, and lipid trafficking. Indeed, these organelles are characterized by continuous events of fission and fusion which contribute to the dynamic plasticity of their network, also strongly influenced by mitochondrial contacts with other subcellular organelles. Nevertheless, mitochondria release a major amount of reactive oxygen species (ROS) inside eukaryotic cells, which are reported to mediate a plethora of both physiological and pathological cellular functions, such as growth and proliferation, regulation of autophagy, apoptosis, and metastasis. Therefore, targeting mitochondrial ROS could be a promising strategy to overcome and hinder the development of diseases such as cancer, where malignant cells, possessing a higher amount of ROS with respect to healthy ones, could be specifically targeted by therapeutic treatments. In this review, we collected the ultimate findings on the blended interplay among mitochondrial shaping, mitochondrial ROS, and several signaling pathways, in order to Citation: Brillo, V.; Chieregato, L.; Leanza, L.; Muccioli, S.; Costa, R. contribute to the dissection of intracellular molecular mechanisms involved in the pathophysiology Mitochondrial Dynamics, ROS, and of eukaryotic cells, possibly improving future therapeutic approaches. Cell Signaling: A Blended Overview. Life 2021, 11, 332. https://doi.org/ Keywords: mitochondrial dynamic; cell signaling; ROS; cancer 10.3390/life11040332 Academic Editors: Giorgio Lenaz and Salvatore Nesci 1. Introduction Mitochondria are intracellular organelles present in eukaryotic cells that evolutionarily Received: 2 March 2021 originated from symbiotic resident proteobacteria [1]. These organelles are involved in Accepted: 7 April 2021 many cellular functions, such as oxidative phosphorylation, the regulation of cell prolif- Published: 10 April 2021 eration, differentiation, and death. Their different roles in several cellular processes are largely dependent on ATP and reactive oxygen species (ROS) production, both generated Publisher’s Note: MDPI stays neutral during oxidative phosphorylation [2]. Indeed, targeting mitochondrial metabolism with with regard to jurisdictional claims in molecules able to specifically disrupt mitochondrial fitness and trigger cell death has published maps and institutional affil- become a promising strategy against several diseases [3]. iations. Importantly, mitochondria are physically interconnected with other subcellular or- ganelles, such as endoplasmic reticulum (ER), lipid droplets, Golgi apparatus, lysosomes, melanosomes, and peroxisomes [4]. Indeed, mitochondria–organelle contact sites represent real signaling hubs that are involved in multiple cellular functions, such as lipid trafficking, Copyright: © 2021 by the authors. mitochondrial dynamics, calcium (Ca2+) flow, and ER stress, such that the contacts not only Licensee MDPI, Basel, Switzerland. result in physical but also functional links that finely tune multiple signaling pathways. This article is an open access article Moreover, the capability to establish these interactions with other intracellular or- distributed under the terms and ganelles is strongly dependent on mitochondria’s high attitude to fuse and divide, leading conditions of the Creative Commons Attribution (CC BY) license (https:// to modification of the intracellular mitochondrial network [5]. creativecommons.org/licenses/by/ In addition, ROS figure as byproducts of oxygen consumption and cellular metabolism, 4.0/). and 45% of their total amount is related to mitochondria, specifically to Complex I and Life 2021, 11, 332. https://doi.org/10.3390/life11040332 https://www.mdpi.com/journal/life Life 2021, 11, x FOR PEER REVIEW 2 of 20 Life 2021, 11, 332 In addition, ROS figure as byproducts of oxygen consumption and cellular metabo-2 of 20 lism, and 45% of their total amount is related to mitochondria, specifically to Complex I and Complex III leakage of electrons, which is involved in superoxide (O2−) and hydrogen peroxide (H2O2) production [6]. While ROS production was at first believed to be only − Complexdetrimental III for leakage the cell of electrons,in physiological which cond is involveditions, in the superoxide last two (Odecades,2 ) and it hydrogen has been peroxideconsidered (H that2O2 )its production presence in [6 a]. sublethal While ROS concentration production could was atact first as a believedsecondary to messen- be only detrimentalger that specifically for the modulates cell in physiological distinct cellular conditions, pathways in the [7] lastand two mitochondrial decades, it dynamics has been consideredand morphology that its [8]. presence As a consequence, in a sublethal concentrationROS homeostasis could is act strictly as a secondary regulated messenger by enzy- thatmatic specifically and nonenzymatic modulates mechanisms, distinct cellular with pathways the aim [of7] maintaining and mitochondrial balance dynamics among ROS and morphologyproduction and [8]. scavenging As a consequence, [9]. Once ROS this homeostasis critical equilibrium is strictly regulatedis impaired, by enzymaticROS overload and nonenzymaticis one of the main mechanisms, players in withthe onset the aim of a of pl maintainingethora of different balance diseases, among including ROS production cancer and[6], where scavenging it exerts [9]. a Oncedual regulation, this critical influencing equilibrium cell is impaired,survival and ROS oxidative overload stress, is one leading of the mainto cell players death, as in well the onset as mediating of a plethora redox of sign differentaling events diseases, beneficial including for cancer the progression [6], where of it exerts a dual regulation, influencing cell survival and oxidative stress, leading to cell death, the disease [9]. as well as mediating redox signaling events beneficial for the progression of the disease [9]. In this review, we describe the known signaling pathways mediated by mitochon- In this review, we describe the known signaling pathways mediated by mitochondrial drial structure rearrangements or by mitochondrial ROS release, focusing also on possible structure rearrangements or by mitochondrial ROS release, focusing also on possible therapeutic targets against disease formation. therapeutic targets against disease formation. 2. Mitochondrial Dynamics: A Multiplayer Regulation Proper mitochondrialmitochondrial integrityintegrity andand physiologyphysiology is is essential essential for for cell cell homeostasis. homeostasis. Mito- Mi- chondrialtochondrial fusion fusion and and fission fission dynamics, dynamics, organelle organelle transport, transport, mitophagy,mitophagy, interactioninteraction withwith other organelles, such as the endoplasmic re reticulumticulum (ER) and the cytoskeleton, and ge- nomic mitochondrial control are only a few of thethe severalseveral mechanismsmechanisms involvedinvolved in thethe fitnessfitness of these fundamental organelles. Thus, the improper surveillance on mitochondrial dynamics andand partitioningpartitioning on on daughter daughter cells cell cans can give give rise rise to a wideto a wide spectrum spectrum of syndromes of syn- anddromes diseases and diseases [5]. [5]. Focusing on the fusion and fissionfission processes,processes, these are mainly regulated by proteins belonging to the dynamin-related family of largelarge GTPases that utilize GTP hydrolysishydrolysis toto drive mechanical work on biological membranes (Figure(Figure1 1))[ 10[10].]. Figure 1. Modulation of fusion and fissionfission processes. Left panel: the endoplasmic reticulumreticulum is wrapping the mitochondria inin thethe sitesite ofof fission,fission, wherewhere polymerspolymers ofof dynamin-relateddynamin-related proteinprotein 1 (DRP1)(DRP1) (main(main interactorinteractor inin thethe fissionfission process)process) areare present.present. Right panel: the two different eventsevents ofof outerouter mitochondrialmitochondrial membranemembrane (OMM)(OMM) fusionfusion andand innerinner mitochondrialmitochondrial membrane (IMM) fusion are separately shown. Essentials components for OMM fusion are Mitofusins. In the IMM fusion membrane (IMM) fusion are separately shown. Essentials components for OMM fusion are Mitofusins. In the IMM fusion process, instead, the role of long and short optic atrophy protein 1 (OPA1) is fundamental, as well as their interaction with cardiolipins. Green arrows point out the positive regulators of these processes, whereas the red ones represent the negative modulators. Life 2021, 11, 332 3 of 20 The membrane potential is also a crucial player in the mitochondrial fission process, by triggering dynamin-related protein 1 (DRP1) activity [11,12]. DRP1 translocates from the cytoplasm to the outer mitochondrial membrane (OMM) via a physical interaction with several adapter proteins, such as mitochondrial
Recommended publications
  • Original Article Withaferin a Activates Stress Signalling Proteins in High Risk Acute Lymphoblastic Leukemia
    Int J Clin Exp Pathol 2015;8(12):15652-15660 www.ijcep.com /ISSN:1936-2625/IJCEP0016078 Original Article Withaferin A activates stress signalling proteins in high risk acute lymphoblastic leukemia Li-Huan Shi1, Xi-Jun Wu2, Jun-Shan Liu1, Yin-Bo Gao3 1Key Laboratory of Paediatric Blood Diseases, Children’s Hospital of Zhengzhou, Zhengzhou 450053, China; 2Guizhou Province Key Laboratory of Regenerative Medicine, Guizhou Medical University, Guiyang 550004, China; 3Department of Science and Technology, Children’s Hospital of Zhengzhou, Zhengzhou 450053, China Received September 13, 2015; Accepted October 23, 2015; Epub December 1, 2015; Published December 15, 2015 Abstract: Withaferin A, the principal bio-active component isolated from the Withaniasomnifera, has shown promis- ing anti-leukemic activity in addition to anti-invasive and anti-metastatic activity. The present study demonstrates the effect of withaferin A on the cell cycle status and the phosphorylation/activation of proteins involved in signal transduction in t(4;11) and non-t(4;11) acute lymphoblastic leukemia (ALL) cell lines after treatment with withaferin A. The cells after treatment with the vehicle or 25 μM withaferin A for 1, 2, 4 and 8 h were examined using flow cyto- metric analysis. The results revealed that withaferin A treatment induced cell growth arrest at the S to G2/M phase transition of the cell cycle. Withaferin A treatment also induced the phosphorylation of stress signalling proteins, including the p38 mitogen-activated protein kinase, the c-Jun N-terminal kinase, c-Jun, the heat shock protein 27 and protein kinase B within 0 to 16 h.
    [Show full text]
  • Mitochondrial Rhomboid PARL Regulates Cytochrome C Release During Apoptosis Via OPA1-Dependent Cristae Remodeling
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Mitochondrial Rhomboid PARL Regulates Cytochrome c Release during Apoptosis via OPA1-Dependent Cristae Remodeling Sara Cipolat,1,7 Tomasz Rudka,2,7 Dieter Hartmann,2,7 Veronica Costa,1 Lutgarde Serneels,2 Katleen Craessaerts,2 Kristine Metzger,2 Christian Frezza,1 Wim Annaert,3 Luciano D’Adamio,5 Carmen Derks,2 Tim Dejaegere,2 Luca Pellegrini,6 Rudi D’Hooge,4 Luca Scorrano,1,* and Bart De Strooper2,* 1 Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, Padova, Italy 2 Neuronal Cell Biology and Gene Transfer Laboratory 3 Membrane Trafficking Laboratory Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB4) and K.U.Leuven, Leuven, Belgium 4 Laboratory of Biological Psychology, K.U.Leuven, Leuven, Belgium 5 Albert Einstein College of Medicine, Bronx, NY 10461, USA 6 Centre de Recherche Robert Giffard, Universite` Laval, G1J 2G3 Quebec, Canada 7 These authors contribute equally to this work. *Contact: [email protected] (L.S.); [email protected] (B.D.S.) DOI 10.1016/j.cell.2006.06.021 SUMMARY been identified in D. melanogaster (Freeman, 2004), where they function as essential activators of the epidermal Rhomboids, evolutionarily conserved integral growth factor (EGF) signaling pathway, proteolytically membrane proteases, participate in crucial sig- cleaving the EGF receptor ligands Spitz, Gurken, and naling pathways. Presenilin-associated rhom- Keren. Since all Rhomboids share a conserved serine boid-like (PARL) is an inner mitochondrial protease catalytic dyad (Lemberg et al., 2005), it has membrane rhomboid of unknown function, been suggested that they are able to cleave proteins in whose yeast ortholog is involved in mito- the transmembrane domain.
    [Show full text]
  • M-AAA and I-AAA Complexes Coordinate to Regulate OMA1, The
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs213546. doi:10.1242/jcs.213546 SHORT REPORT m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics Francesco Consolato1,*, Francesca Maltecca1,*, Susanna Tulli1, Irene Sambri2 and Giorgio Casari1,2,‡ ABSTRACT and fission (L and S forms, respectively) (Anand et al., 2014). The The proteolytic processing of dynamin-like GTPase OPA1, mediated balance between long and short OPA1 forms is finely regulated by two by the activity of both YME1L1 [intermembrane (i)-AAA protease mitochondrial inner membrane proteases, OMA1 (Ehses et al., 2009) complex] and OMA1, is a crucial step in the regulation of mitochondrial and YME1L1, which cleave OPA1 at different sites (Song et al., 2007). dynamics. OMA1 is a zinc metallopeptidase of the inner mitochondrial The intermembrane (i)-AAA protease YME1L1 exposes its membrane that undergoes pre-activating proteolytic and auto- catalytic domain to the intermembrane space (Leonhard et al., 1996) proteolytic cleavage after mitochondrial import. Here, we identify and is responsible for generation of the S2-OPA1 form by proteolytic AFG3L2 [matrix (m)-AAA complex] as the major protease mediating cleavage, whereas OMA1 gives rise to the S1 and S3 forms (Anand this event, which acts by maturing the 60 kDa pre-pro-OMA1 to the et al., 2014; MacVicar and Langer, 2016; Quirós et al., 2012). 40 kDa pro-OMA1 form by severing the N-terminal portion without OMA1 harbours an M48 metallopeptidase domain and is the major recognizing a specific consensus sequence. Therefore, m-AAA and player in OPA1 processing under conditions of stress (Quirós et al., Δϕ i-AAA complexes coordinately regulate OMA1 processing and 2012).
    [Show full text]
  • PARL (Human) Recombinant Protein (P01)
    Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic PARL (Human) Recombinant Protein Gene Alias: PRO2207, PSARL, PSARL1, PSENIP2, (P01) RHBDS1 Gene Summary: This gene encodes a mitochondrial Catalog Number: H00055486-P01 integral membrane protein. Following proteolytic Regulation Status: For research use only (RUO) processing of this protein, a small peptide (P-beta) is formed and translocated to the nucleus. This gene may Product Description: Human PARL full-length ORF ( be involved in signal transduction via regulated NP_061092.3, 1 a.a. - 379 a.a.) recombinant protein with intramembrane proteolysis of membrane-tethered GST-tag at N-terminal. precursor proteins. Variation in this gene has been associated with increased risk for type 2 diabetes. Sequence: Alternative splicing results in multiple transcript variants MAWRGWAQRGWGCGQAWGASVGGRSCEELTAVLT encoding different isoforms. [provided by RefSeq] PPQLLGRRFNFFIQQKCGFRKAPRKVEPRRSDPGTSG EAYKRSALIPPVEETVFYPSPYPIRSLIKPLFFTVGFTGC
    [Show full text]
  • RESEARCH ARTICLE Effect of Withaferin a on A549 Cellular
    DOI:http://dx.doi.org/10.7314/APJCP.2014.15.4.1711 Effects of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer Cells RESEARCH ARTICLE Effect of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer Yong Cai1, Zhao-Ying Sheng1, Yun Chen1, Chong Bai2* Abstract Objective: To explore the effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer (NSCLC). Materials and Methods: NSCLC cell line A549 was selected to explore the effect of Withaferin A on A549 cellular proliferation, apoptosis and the PI3K/Akt signal pathway capable of regulating tumor biological behavior by assessment of cellular proliferation, cellular apoptotic rates and cellular cycling as well as by immuno-blotting. Results: Withaferin A could inhibit A549 cellular proliferation and the control rate was dosage-dependent (P<0.05), which also increased time-dependently with the same dosage of Withaferin A (P<0.05). The apoptotic indexes in A549 cells treated with 0, 2.5, 5.0, 10.0 and 20.0 μmol·L-1 Withaferin A for 48 h were significantly different (P<0.05). In addition, the apoptotic rates of each group in both early and advanced stages were higher than those in 0 μmol·L-1 (P<0.05), which were evidently higher after 48 h than those after 24 h (P<0.05). A549 cells treated by Withaferin A for 48 h were markedly lower in Bcl-2 level and obviously higher in Bax and cleaved caspase-3 levels than those treated by 0 μmol·L-1 Withaferin A (P<0.05), and there were significant differences among 5, 10 and 20 μmol·L-1 Withaferin A (P<0.05).
    [Show full text]
  • Original Article Withaferin a Inhibits Hepatoma Cell Proliferation Through Induction of Apoptosis and Cell Cycle Arrest
    Int J Clin Exp Pathol 2016;9(12):12381-12389 www.ijcep.com /ISSN:1936-2625/IJCEP0034496 Original Article Withaferin A inhibits hepatoma cell proliferation through induction of apoptosis and cell cycle arrest Yue-Fen Zhou1*, Xue-Tao Yu2*, Jing-Jing Yao3*, Chun-Wei Xu4, Jian-Hui Huang1, Yang Wan5, Mei-Juan Wu6 1Department of Oncology, Lishui Central Hospital, Lishui Hospital of Zhejiang University, Lishui 323000, Zhejiang, People’s Republic of China; 2Department of Medical Oncology, Tianyou Hospital, Tongji University, Shanghai 200311, People’s Republic of China; 3Department of Digestive Internal Medicine, People’s Hospital of Rizhao, Rizhao 276826, Shandong, People’s Republic of China; 4Department of Pathology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, People’s Republic of China; 5Department of Pathology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, People’s Republic of China; 6Department of Pathology, Zhejiang Cancer Hospital, Hangzhou 310022, People’s Republic of China. *Co- first authors. Received June 27, 2016; Accepted August 2, 2016; Epub December 1, 2016; Published December 15, 2016 Abstract: Withaferin A (WFA) is an active compound from Withania somnifera and has been reported to exhibit a variety of pharmacological activities such as anti-inflammatory and anti-cancer activities. In the present study, we investigated the anti-proliferative effect of WFA on human hepatocellular carcinoma (HCC) cells and the molecular mechanism underlying the cytotoxicity of WFA. We found that treatment with WFA obviously inhibited HCC cells proliferation in a dose and time-dependent manner. Moreover, the apoptosis rate of HCC cells was significantly increased in the presence of WFA.
    [Show full text]
  • Exploring the Multifaceted Therapeutic Potential of Withaferin a and Its Derivatives
    biomedicines Review Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives Tapan Behl 1,*, Aditi Sharma 2, Lalit Sharma 2, Aayush Sehgal 1, Gokhan Zengin 3, Roxana Brata 4, Ovidiu Fratila 4 and Simona Bungau 5,* 1 Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India; [email protected] 2 School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh 173229, India; [email protected] (A.S.); [email protected] (L.S.) 3 Department of Biology, Faculty of Science, Selcuk University Campus, Konya 42250, Turkey; [email protected] 4 Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania; [email protected] (R.B.); [email protected] (O.F.) 5 Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania * Correspondence: [email protected] (T.B.); [email protected] (S.B.); Tel.: +91-852-517-931 (T.B.); +40-726-776-588 (S.B.) Received: 20 November 2020; Accepted: 4 December 2020; Published: 6 December 2020 Abstract: Withaferin A (WA), a manifold studied, C28-steroidal lactone withanolide found in Withania somnifera. Given its unique beneficial effects, it has gathered attention in the era of modern science. Cancer, being considered a “hopeless case and the leading cause of death worldwide, and the available conventional therapies have many lacunae in the form of side effects. The poly pharmaceutical natural compound, WA treatment, displayed attenuation of various cancer hallmarks by altering oxidative stress, promoting apoptosis, and autophagy, inhibiting cell proliferation, reducing angiogenesis, and metastasis progression. The cellular proteins associated with antitumor pathways were also discussed.
    [Show full text]
  • Genetic Correction of HAX1 in Induced Pluripotent Stem Cells from a Patient with Severe Congenital Neutropenia Improves Defective Granulopoiesis
    Bone Marrow Failure Syndromes ARTICLES Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis Tatsuya Morishima,1 Ken-ichiro Watanabe,1 Akira Niwa,2 Hideyo Hirai,3 Satoshi Saida,1 Takayuki Tanaka,2 Itaru Kato,1 Katsutsugu Umeda,1 Hidefumi Hiramatsu,1 Megumu K. Saito,2 Kousaku Matsubara,4 Souichi Adachi,5 Masao Kobayashi,6 Tatsutoshi Nakahata,2 and Toshio Heike1 1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto; 2Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto; 3Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto; 4Department of Pediatrics, Nishi-Kobe Medical Center, Kobe; 5Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto; and 6Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan ABSTRACT HAX1 was identified as the gene responsible for the autosomal recessive type of severe congenital neutropenia. However, the connection between mutations in the HAX1 gene and defective granulopoiesis in this disease has remained unclear, mainly due to the lack of a useful experimental model for this disease. In this study, we generated induced pluripotent stem cell lines from a patient presenting for severe congenital neutropenia with HAX1 gene deficiency, and analyzed their in vitro neutrophil differentiation potential by using a novel serum- and feeder-free directed differentiation culture system. Cytostaining and flow cytometric analyses of myeloid cells differentiated from patient-derived induced pluripotent stem cells showed arrest at the myeloid progenitor stage and apoptotic predisposition, both of which replicated abnormal granulopoiesis. Moreover, lentiviral transduction of the HAX1 cDNA into patient-derived induced pluripotent stem cells reversed disease-related abnormal granulopoiesis.
    [Show full text]
  • Human CLPB) Is a Potent Mitochondrial Protein Disaggregase That Is Inactivated By
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Skd3 (human CLPB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations Ryan R. Cupo1,2 and James Shorter1,2* 1Department of Biochemistry and Biophysics, 2Pharmacology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A. *Correspondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Cells have evolved specialized protein disaggregases to reverse toxic protein aggregation and restore protein functionality. In nonmetazoan eukaryotes, the AAA+ disaggregase Hsp78 resolubilizes and reactivates proteins in mitochondria. Curiously, metazoa lack Hsp78. Hence, whether metazoan mitochondria reactivate aggregated proteins is unknown. Here, we establish that a mitochondrial AAA+ protein, Skd3 (human CLPB), couples ATP hydrolysis to protein disaggregation and reactivation. The Skd3 ankyrin-repeat domain combines with conserved AAA+ elements to enable stand-alone disaggregase activity. A mitochondrial inner-membrane protease, PARL, removes an autoinhibitory peptide from Skd3 to greatly enhance disaggregase activity. Indeed, PARL-activated Skd3 dissolves α-synuclein fibrils connected to Parkinson’s disease. Human cells lacking Skd3 exhibit reduced solubility of various mitochondrial proteins, including anti-apoptotic Hax1.
    [Show full text]
  • Withaferin a Suppresses Liver Tumor Growth in a Nude Mouse Model by Downregulation of Cell Signaling Pathway Leading to Invasion and Angiogenesis
    Wang et al Tropical Journal of Pharmaceutical Research June 2015; 14 (6): 1005-1011 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v14i6.10 Original Research Article Withaferin A Suppresses Liver Tumor Growth in a Nude Mouse Model by Downregulation of Cell Signaling Pathway Leading to Invasion and Angiogenesis Yu-Xu Wang*, Wei-Bao Ding and Cheng-Wei Dong Department of Hepatobiliary Surgery, Weifang People’s Hospital, Weifang 261041, China *For correspondence: Email: [email protected]; Tel/Fax: 0086-536-8234981 Received: 23 November 2014 Revised accepted: 19 May 2015 Abstract Purpose: To investigate the effect of withaferin A on tumor growth and metastasis in liver in a nude mouse model. Methods: Withaferin A was injected through a portal vein to the orthotopic liver tumor in a nude mice model. Xenogen in vivo imaging system was used to monitor tumor growth and metastasis. The effect of withaferin A on tumor volume, invasive growth pattern, expression of Pyk2, upregulation of BAX/P53, apoptotic signaling and ROCK/IP10/VEGF pathway along with cytoskeletal protein actin projection formation was studied. Tumor/non-tumor margin was examined under electron microscopy. In addition, the direct effect of withaferin A on liver cancer cells and endothelial cells was further investigated. Results: A significant inhibition of tumor growth and lower incidence of lung metastasis was observed after withaferin A treatment. Withaferin A treatment led to a decrease in the incidence of intrahepatic metastasis from 90 (9 of 10) to 10 % (1 of 10, p = 0.041).
    [Show full text]
  • Withaferin a Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington’S Disease
    Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington’s Disease Tripti Joshi National Brain Research Centre Vipendra Kumar National Brain Research Centre Elena V Kaznacheyeva Institute of Cytology Russian Academy of Sciences: FGBUN Institut citologii Rossijskoj akademii nauk Nihar Ranjan Jana ( [email protected] ) Indian Institute of Technology Kharagpur https://orcid.org/0000-0002-6549-4211 Research Article Keywords: Impairment , proteostasis network, neurodegenerative , Huntington’s disease (HD) Posted Date: March 2nd, 2021 DOI: https://doi.org/10.21203/rs.3.rs-255652/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/30 Abstract Impairment of proteostasis network is one of the characteristic features of many age-related neurodegenerative disorders including autosomal dominantly inherited Huntington’s disease (HD). In HD, N-terminal portion of mutant huntingtin protein containing expanded polyglutamine repeats accumulates as inclusion bodies and leads to progressive deterioration of various cellular functioning including proteostasis network. Here we report that Withaferin A (a small bioactive molecule derived from Indian medicinal plant, Withania somnifera) partially rescues defective proteostasis by activating heat shock response (HSR) and delay the disease progression in a HD mouse model. Exposure of Withaferin A activates HSF1 and induces the expression of HSP70 chaperones in an in vitro cell culture system and also suppresses mutant huntingtin aggregation in a cellular model of HD. Withaferin A treatment to HD mice considerably increased their lifespan as well as restored progressive motor behavioural decits and declined body weight. Biochemical studies conrmed the activation of HSR and global decrease in mutant huntingtin aggregates load accompanied with improvement of striatal function in Withaferin A treated HD mice brain.
    [Show full text]
  • The Incomplete Puzzle of the BCL2 Proteins
    cells Perspective The Incomplete Puzzle of the BCL2 Proteins Hector Flores-Romero and Ana J. García-Sáez * Interfaculty Institute of Biochemistry, Eberhard-Karls-Universität Tübingen, 72076 Tübingen, Germany; [email protected] * Correspondence: [email protected] Received: 3 September 2019; Accepted: 26 September 2019; Published: 29 September 2019 Abstract: The proteins of the BCL2 family are key players in multiple cellular processes, chief amongst them being the regulation of mitochondrial integrity and apoptotic cell death. These proteins establish an intricate interaction network that expands both the cytosol and the surface of organelles to dictate the cell fate. The complexity and unpredictability of the BCL2 interactome resides in the large number of family members and of interaction surfaces, as well as on their different behaviours in solution and in the membrane. Although our current structural knowledge of the BCL2 proteins has been proven therapeutically relevant, the precise structure of membrane-bound complexes and the regulatory effect that membrane lipids exert over these proteins remain key questions in the field. Here, we discuss the complexity of BCL2 interactome, the new insights, and the black matter in the field. Keywords: BCL2 proteins; MOMP; protein membrane interactions; apoptosis; cancer therapy Perspective in BCL2 Universe The proteins of the BCL2 family are the main regulators of the intrinsic apoptotic pathway and constitute a fundamental part of tumorigenic cell dismissal and cancer treatment effectiveness [1,2]. Apoptosis effectors, or BAX-type proteins, are the most effective removers of damaged cells, while their antiapoptotic counterparts, or BCL2-type proteins, inhibit apoptotic cell death and play a role in chemotherapeutic resistance [3,4].
    [Show full text]